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บทคดัยอ่  
วตัถปุระสงค:์ เพือ่วเิคราะหปั์จจยัทีส่ง่ผลตอ่โอกาสการเกดิภาวะไตเสือ่มในผูป่้วย
เบาหวานในโรงพยาบาลชุมชน วิธีการศึกษา: การศึกษาเชิงวิเคราะห์แบบ
ยอ้นหลงั ประชากรทีศ่กึษาคอื ผูป่้วยโรคเบาหวานในคลนิิก รพ.บ้านนา จ านวน 
3,250 คน สุ่มตัวอย่างแบบเป็นระบบ (Systematic random sampling)  โดย
เรยีงล าดบัตาม HN 1 คนเวน้ 1 คน ไดค้นไข ้1,254 คน ใชส้ถติไิดแ้ก่ คา่เฉลีย่เลข
คณิต ส่วนเบี่ยงเบนมาตรฐาน ค่าความถี่ ร้อยละ การวเิคราะห์ปัจจยัที่ส่งผลต่อ
โอกาสการเกิดภาวะไตเสื่อมของผู้ป่วยโรคเบาหวาน โดยใช้ค่า eGFR สะท้อน
ระดับภาวะไตเสื่อม ใช้การวิเคราะห์สมการถดถอยเชิงเส้น (stepwise linear 
regression) ผลการศึกษา: ปัจจัยที่มีผลต่อโอกาสระดับ eGFR ของผู้ป่วย
โรคเบาหวานอยา่งมนีัยส าคญั (P-value < 0.05) ไดแ้ก่ ค่าชวีเคม ีซึง่ค่าทีส่มัพนัธ์
ทางลบ ไดแ้ก่ creatinine ในเลอืด (B = -44.28), HbA1C (B = -1.08) และ BUN 
(B = -0.49) และสมัพนัธ์ทางบวกกบั HDL (B = 0.06) โดยทัง้หมดอธบิายความ
แปรปรวนของค่า eGFR ได้ร้อยละ 75 (R2 = 0.75) ส่วนปัจจยัด้านพฤตกิรรม
สุขภาพมเีพยีงพฤตกิรรมการดื่มสุราหรอืเครื่องดื่มที่มแีอลกอฮอลที่สมัพนัธ์กบั
ระดบั eGFR ทางลบอย่างมนีัยส าคญัทางสถิต ิ(B = -1.488) โดยอธบิายความ
แปรปรวนของระดบั eGFR ไดร้อ้ยละ 15 ทัง้นี้ ค่าดชันีมวลรวมของร่างกาย (B = 
-0.407) และระยะเวลาเป็นเบาหวาน (B = -0.377) ที่สมัพนัธ์กบั eGFR อย่างมี
นัยส าคญัทางสถติิและสามารถท านายความแปรปรวนของ eGFR ได้ร้อยละ 19 
สรุป: ปัจจัยที่ส่งผลต่อโอกาสเกิดภาวะไตเสื่อมของผู้ป่วยเบาหวาน ได้แก่ 
creatinine HbA1C BUN HDL การดืม่สุราหรอืเครือ่งดืม่ทีม่แีอลกอฮอล ์ระยะเวลา
ทีเ่ป็นเบาหวาน และดชันีมวลรวมของรา่งกาย  
ค าส าคญั: เบาหวาน, ภาวะไตเสือ่ม, ปัจจยัเสีย่ง 
 
 
 
 Abstract 
Objective: To determine factors affecting the risk of kidney failure in diabetes 
patients in community hospital. Method:  In this retrospective study, study 
population was 3,250 patients in diabetic clinic at Banna Hospital. A sample 
of 1,254 patients was selected using systematic random sampling with 
alternate HN. Descriptive statistics with mean with standard deviation and 
frequency with percentage were used. Stepwise linear regression analysis 
was used to examine factors affecting the eGFR as kidney failure indicator. 
Results: Factors significantly associated with eGFR (P-value < 0.05) were 
biochemistry factors with serum creatinine (B = -44.28), HbA1C (B = -1.08) 
and BUN (B = -0 . 4 9 )  of negative relation and HDL (B = 0 . 0 6 )  of positive 
relation. These factors could explain 75% of eGFR variance (R2 = 0.75). For 
health behavior factors, only alcohol or alcoholic beverage intake was 
negatively associated with eGFR (B = -1 . 4 8 8 )  with 15% eGFR variance 
exaplained. In addition, body mass index (BMI) (B = -0.407) and duration of 
diabetes diagnosis (B = -0.377) were associated with eGFR with 19% 
variance explained. Conclusion: Factors affecting the decline of eGFR were 
serum creatinine, HbA1C, BUN, HDL, alcohol or alcoholic beverage intake, 
duration of diabetes diagnosis and BMI.  
Keywords: diabetes, kidney failure, risk factors  
  
 
 
 
  
Introduction 
Type 2 diabetes mellitus has been an epidemic worldwide 
and Thailand was no exception. 0042ased on the data from 
the Diabetes Association of Thailand, it has been predicted 
that there will be a total of 642 cases of type 2 diabetes in 
2045 worldwide.1  As a critical public health problem of 
Thailand, the treatment of diabetes aims at lengthening the 
patient’s lifespan and avoiding complications especially end-
stage renal disease (ESRD). Chronic kidney disease (CKD) 
has been a global problem. In Thailand, and the study of Thai 
Medical Research Netowkr (MedResNet) reported that 
prevalence of CKD in diabetes patients in 2009 was 17.5%.2 
At present, the annual expenditure for renal replacement 
therapy, both continuous ambulatory peritoneal dialysis 
(CAPD) and hemodialysis was approximately 240,000 baht 
per patient. This expenditure has posed a high medical burden 
for the patient, their family and the public as a whole.  
Based on the Thailand Renal Replacement Therapy 
Registry 2013 report3, the major cause of ESRD undergoing 
renal replacement therapy was diabetes (37.5%). A total of 20 
– 40% of type 2 diabetes were more likely to develop diabetic 
kidney disease.4 The individuals were advanced to CKD and 
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eventually ESRD. With a higher prevalence of diabetes, a 
greater incidence of diabetes-related CKD was found.5,6  
Based on the policy to reduce CKD incidence, the main 
indicators in the fiscal year of 2016 was at least 50% of the 
CKD patients could show down kidney impairment 
progression (a decline rate of eGFR of less than 4 ml/min/1.73 
m2). Based on the seven measures for management of CKD, 
it is indicated to prevent and slow down the progression of 
CKD in those with stage 1 – 3 CKD, and slow down the 
progression to ESRD in those with stage 4 – 5. In addition, it 
is recommended to promote the environment healthy to CKD 
patients, decrease risk factors, and promote CKD 
management in the community.6 In the health administration 
region 4, only 62.80% of CKD patients could slow down the 
CKD progression which was in the 9th of all 12 regions. 
As a hospital in the health administration region 4, Banna 
Community Hospital took care of a large number of diabetes 
patients. A number of diabetes patients at the out-patient 
department have increased from 2,768 to 2,950 and 3,250 
cases in 2016, 2017 and 2018, respectively. A number of 
stage 3 – 5 CKD cases among diabetes patients have also 
been increasing every year. 
The pression of CKD among diabetes patients resulted in 
a great financial burden and a high mortality risk. In Somdej 
Prapinklao Hospital, diabetes patients with renal complications 
had levels of BUN, serum creatinine, uric acid and urine 
albumin creatinine ratio significantly higher than those with no 
complications.7 Factors predicting CKD in diabetes patients 
included uncontrolled glycemic status (as HbA1C), having co-
morbidities, uncontrolled blood pressure, high-fat food intake, 
high diastolic blood pressure, high triglyceride, age of 70 – 79 
years, and high LDL cholesterol.8 Self-management program 
with the motivational interview was found effective in slowing 
down the pression of CKD in diabetes patients with stage 3 
CKD as evidence with an increased in GFR, a persistent 
serum creatinine level, and a decrease in urine albumin.9 In 
addition, HbA1C was negatively related with eGFR; the lower 
HbA1C could result in a lower serum creatinine level and an 
increase in GFR.10 The Ministry of Public Health also passed 
a policy promoting the prevention of stage 1 – 3 CKD which 
could progress to ESRD requiring a nationwide high financial 
burden renal replacement therapy.6  
With all circumstances elaborated above and a great 
concern on the foreseeable burden, we aimed to determine 
factors potentially affecting renal impairment progression 
among diabetes patients of Banna Hospital. With its 
community care orientation, the context of care of this 
community hospital could be different from other levels of 
care. Specifically, we aimed to investigate the effects of 
demographic characteristics, blood sugar level, blood lipid 
level, kidney function levels, health behaviors, and 
comorbidities on the GFR level as the indicator of renal 
impairment in CKD. Prevalence of CKD regarding chronic 
renal failure levels in diabetes patients was also determined. 
The findings could be used to predict the progression of CKD 
in individual diabetes patients at community hospital level. The 
prediction of such progression is of great importance since 
early stage CKD shows no obvious signs or symptoms. Early 
detection and prediction of CKD progression could prompt a 
timely referral to the tertiary care settings for kidney disease 
specialists.  
  
Methods 
 
In this retrospective study, secondary data of diabetes 
patients from the HOSxP database of Banna Community 
Hospital, Banna district, Nakhonnayok province, were used. 
Based on the data of 3,250 diabetes patients from 2016 to 
2018, the sample was drawn using a systematic random 
sampling on an alternative hospital number (HN). The sample 
size was estimated based on Yamane’s concept. With a finite 
study population of 3,250 patients and an error of 0.025, a 
sample size of 1,130 was required. 
To be eligible, the patients had to have type 2 diabetes 
and in the diabetes clinic. They also needed to have screening 
for kidney function impairment and behavior practice data from 
the 3O2S form of the Ministry of Public Health. Patient records 
with a missing of any of the study variables mentioned above 
were excluded. As a result, 1,254 patients were obtained.  
  
Study instruments  
Data collection form consisted of five sections. In the first 
section, demographic characteristics were collected including 
gender, age, education level, occupation, and residence. The 
second part collected laboratory data including lipid profile 
(cholesterol, triglyceride, LDL and HDL), kidney functions 
(BUN, serum creatinine, eGFR), and glycemic control (HbA1C 
and FBS). In the third section, health behavior of the patient 
was collected using the 3O2S form of the Ministry of Public 
Health including diet, exercise, smoking, and moods.11 The 
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frequency of practicing each behavior was graded into five 
levels of not practicing at all, 1 – 2 days/week, 3 days/week, 
4 - 5 days/week, and 6 - 7 days/week. The fourth section 
collected the patient’s illness including duration of diabetes 
since diagnosed and body mass index (BMI). In the last 
section, the patient’s risk of chronic renal failure (CRF) was 
graded based on their GFR levels into CRF levels 1 (no CRF), 
2 (low CRF), 3 (moderate CRF), 4 (severe CRF) and 5 
(ESRD) for GFR of > 90, 60 – 89, 30 – 59, 15 – 29, and < 15 
mL/min., respectively.  
  
Statistical analysis  
Descriptive statistics including frequency with percentage 
and mean with standard deviation were used for demographic 
and clinical characteristics of the participants. Three stepwise 
linear regression analyses were performed on GFR as a 
dependent variable and three sets of independent variables, 
specifically, 1) laboratory biochemistry factors, 2) health 
behavior factors, and 3) health status factors. All statistical 
significance was set at a type I error of 5% (or P-value < 0.05). 
Statistical analysis was conducted using a free statistical 
software program.13  
   
Results 
 
Of the 1,254 type 2 diabetes patients in the out-patient 
clinic of Banna Hospital, the majority were female (70.10%), 
in their 61 – 70 years of age (31.90%) with an average age of 
62.57 (a range of 20 – 97 years), and general labors as their 
occupation (47.77%). Laboratory biochemistry factors are 
detailed in Table 1.  
 
 Table 1  Laboratory biochemistry factors of the 
participants (N = 1,254).   
 
Mean 
Standard 
deviation 
Max. Min. 
Serum total cholesterol (mg%) 193.81 44.59 398.00 90.00 
Serum triglyceride (mg%) 161.73 76.25 803.00 37.00 
Serum LDL cholesterol (mg%) 114.72 38.77 254.00 24.00 
Serum HDL cholesterol (mg%) 46.74 15.00 114.00 10.00 
Serum BUN (mg/dl) 16.23 7.86 85.00 4.00 
Serum creatinine (mg/l) 0.93 0.55 11.10 .30 
Serum glucose (mg/dl)   148.11 50.41 412.00 62.00 
Hb A1c (%)   7.74 1.94 18.10 3.10 
 
For health behaviors, the majority of participants practice 
1) diet control on the intake and salt, sugar, and fat 3 days 
per weeks (29.19%), 2) consumption of fruit and vegetable of 
at least half a kilogram daily 3 days a week (48.25%), 3) 
exercise or continuous movement of the body to the 
exhaustion 3 days a week (40.59%), 4) no stress control by 
projecting a positive outlook on life (mood control) (99.36%), 
5) no cigarette smoking or second-hand smoking (97.85%), 
and 6) alcohol or alcoholic beverage intake 3 days a week 
(39.79%) (Table 2).  
 
 Table 2  Health behaviors of the participants (N = 
1,254).   
Health behaviors Practice level N % 
Diet control on the intake and salt, 
sugar, and fat  
No practice 95 7.58 
1 – 2 days / week 297 23.68 
3 days / week 366 29.19 
4 – 5 days / week 356 28.39 
6 – 7 days / week 140 11.16 
Consumption of fruit and vegetable of 
at least half a kilogram daily 
No practice 63 5.02 
1 – 2 days / week 275 21.93 
3 days / week 605 48.25 
4 – 5 days / week 273 21.77 
6 – 7 days / week 38 3.03 
Exercise or continuous movement of 
the body to the exhaustion 
No practice 175 13.96 
1 – 2 days / week 450 35.89 
3 days / week 509 40.59 
4 – 5 days / week 116 9.25 
6 – 7 days / week 4 0.32 
Stress control by projecting a positive 
outlook on life (mood control) 
No practice 1246 99.36 
1 – 2 days / week 6 0.48 
3 days / week 0 0.00 
4 – 5 days / week 0 0.00 
6 – 7 days / week 2 0.16 
Cigarette smoking or second-hand 
smoking 
No practice 1227 97.85 
1 – 2 days / week 22 1.75 
3 days / week 5 0.40 
4 – 5 days / week 0 0.00 
6 – 7 days / week 0 0.00 
Alcohol or alcoholic beverage intake No practice 382 30.46 
1 – 2 days / week 288 22.97 
3 days / week 499 39.79 
4 – 5 days / week 84 6.70 
6 – 7 days / week 1 0.08 
 
The patients were diagnosed with diabetes for 9.23 years 
by average with the majority being diagnosed for 6 – 10 years 
(32.22%). By average they were overweight with a mean BMI 
of 25.69 kg/m2 and a mean waist circumference of 33.85 
inches (Table 3).  
 
 Table 3  Health status of the participants (N = 1,254).   
Health status Mean S.D. Max. Min. 
Duration of diabetes since 
diagnosed (yrs) 
9.23 5.40 32.00 1.00 
BMI (kg/m2) 25.69 4.62 46.09 13.62 
Waist circumference (inches) 33.85 3.44 52.00 22.40 
 
Since Banna Hospital is a community hospital, the majority 
of the patients were classified as level 1 chronic renal failure 
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(CRF) (45.35%), followed by levels 2 (32.35%), 3 (19.01%), 4 
(2.63%) and 5 (0.66%), respectively (Table 4).  
 
 Table 4   Prevalence of chronic renal failure (CRF) of 
the participants (N = 1,254).   
Risk to CRF based on GFR N (%) 
Level 1: renal damage was found; GFR > 90 mL/min.  551 (45.35) 
Level 2: renal damage was found with slight decrease of GFR; 
GFR 60 – 89 mL/min. 
393 (32.35) 
Level 3: renal damage was found with moderate decrease of 
GFR; GFR 30 – 59 mL/min.  
231 (19.01) 
Level 4: renal damage was found with severe decrease of GFR; 
GFR 15 – 29 mL/min.  
32 (2.63) 
Level 5: end-stage renal disease; GFR < 15 mL/min. 8 (0.66) 
 
Based on stepwise linear regression analysis, GFR level 
was significantly negatively associated with serum creatinine 
level (B = -44.28), HbA1C (B = -1.08), and serum BUN (B = -
0.49), and positively with serum HDL (B = 0.06) (Table 5). 
These 4 biochemistry factors could explain as high as 75% of 
the variance of GFR.  
 
 Table 5  Relationship between GFR and 
biochemistry factors by stepwise linear regression analysis of 
the participants (N = 1,254).   
Variables  B Std. Error  T P-value 
Constant 131.780 2.688  49.02 < 0.001 
Serum creatinine (mg/dl) -44.28 2.52 -0.587 -17.55 < 0.001 
HbA1C (%)   -1.08 .211 0.453 -5.14 < 0.001 
Serum BUN (mg/dl) -0.49 .108 -0.154 -4.56 < 0.001 
Serum HDL (mg/dl)   0.06 .029 -0.062 2.08 < 0.001 
R2 = 0.75, Adjusted R2 = 0.445, F = 409.64, P-value < 0.001 
 
Regarding health behavior factors, only alcohol or 
alcoholic beverage intake was significantly negatively 
associated with GFR (B = -1.488) (Table 6). This single health 
behavior factor could explain 15% of the GFR.  
 
 Table 6  Relationship between GFR and health 
behavior factors by stepwise linear regression analysis of the 
participants (N = 1,254).   
Variables  B Std. Error  T P-value 
Constant 105.18 1.473  71.42 < 0.001 
Alcohol or alcoholic beverage 
intake 
-1.488 0623 -.098 -2.387 0.017 
R2 = 0.15, Adjusted R2 = 0.008, F = 5.67, P-value = 0.01 
 
Regarding health status factors, GFR was significantly 
negatively associated with BMI (B = -0.407) and duration of 
diabetes diagnosis B = -0.377) (Table 7). These two health 
status factors could explain 19% of the GFR.  
 
 Table 7  Relationship between GFR and health 
status factors by stepwise linear regression analysis of the 
participants (N = 1,254).   
Variables  B Std. Error  T P-value 
Constant 94.47 3.633  15.05 < 0.001 
BMI -0.407 0.127 -0.136 -3.191 0.001 
Duration of diabetes since 
diagnosed 
-0.377 0.113 0.130 -3.323 0.001 
R2 = 0.19, Adjusted R2 = 0.021, F = 12.12, P-value < 0.001 
 
In short, GFR level was significantly negatively associated 
with serum creatinine, HbA1C, serum BUN, alcohol or 
alcoholic beverage intake, BMI and duration of diabetes 
diagnosis, positively with serum HDL. 
  
 
Discussions and Conclusion 
 
Our study found that the decline of GFR in type 2 diabetes 
patients was associated with the increase in serum creatinine, 
HbA1C, serum BUN, alcohol or alcoholic beverage intake, BMI 
and duration of diabetes since diagnosed. This finding was 
consistent with the study of Zoppini et al where HbA1C was 
associated with eGFR.10 They found that a well controlled 
HbA1C could result in a lower serum creatinine level, which 
meant a higher level of GFR. Our finding was also consistent 
with the study of Janjumras and Pipatsatitpong.7 However, our 
study did not include uric acid and urine albumin creatinine 
ratio (UACR) as predicting factors since there was a limitation 
of laboratory data of uric acid and albumin in a certain portion 
of the patients. In addition, our study did not find that 
triglyceride and LDL cholesterol were associated with the 
decline of GFR which was different from the study of 
Wongprakob and Piyabunditkul where the two parameters 
were associated with the decline of GFR.8 The study of 
Tattumlae also found that LDL cholesterol was also associated 
with the CKD progression.14  
In terms of effects of health behaviors based on the 3O2S 
of the Ministry of Public Health on CKD progression12, alcohol 
or alcoholic beverage consumption was the only one with 
significant association with the decline in GFR in type 2 
diabetes patients. Our finding was different from previous 
studies. Mood management, exercise and proper diet were 
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found to associate with a slower rate of GFR decline in the 
study of Tattumlae14, while noncompliance to diabetic drugs, 
herbal use, no physical exercise, obesity, stress, smoking, and 
alcohol intake were associated with the GFR decline among 
diabetes patients with stage 1 – 3 CKD in the study of 
Chailimlamontri and Kantachuwessiri.15 In our study, 
compliance to diabetic medications was not examined. 
For the health status factors, only duration of diabetes 
since diagnosed and BMI but not waist circumference were 
significantly associated with the decline in GFR. This was 
consistent with the study of Dejma and co-workers where 
duration of diabetes since diagnosed was able to explain 
11.9% of the variance of kidney complications.16 In the study 
of Laksawut, a duration of greater than 5 years since 
diagnosed with diabetes was associated with a 1.99-fold risk 
of kidney failure.17 The study of Utsakarn and colleagues 
found that kidney failure progression was associated with 
duration of diabetes diagnosis.18 The study of Dodhia also 
showed that a shorter duration of diabetes diagnosis was 
associated with a 2.08-fold higher eGFR.5 The study on 
epidemiology of chronic kidney failure among diabetes 
patients in Thailand reported that the median times to 
progress to CKD from G1-G2, G2-G3a, G3a-G3b, G3b-G4, 
G4-G5 were 4.4, 6.1, 4.9, 6.3 and 9 years, respectively 
compared with 9.4, 14.0, 11.0, 13.8 and more than 14.3 years, 
respectively for other patients.19 For BMI, Sungkhang and 
Wangkaew also reported that the risk of CKD in type 2 
diabetes patients was increased 1.49 folds with those 1 unit 
of BMI.20  
In terms of prevalence of CKD among type 2 diabetes 
patients, most patients were classified as stage 1 CKD. The 
number of patients with later CKD stages were fewer. This 
finding was as expected since the study setting is a 
community hospital where early stage of CKD could be 
expected and later stages should be referred to tertiary care 
settings.  
Banna Hospital has developed a CKD clinic to slow down 
the progression of kidney disease in patients with kidney 
disease and those with the risk of CKD. Our finding could be 
useful in screening the ear sign of kidney disease such as 
microaluminuria screening which could prompt the urgent 
need to for special care for kidney disease. The association 
of HbA1C which reflects glycemic control from the last three 
months and the progression of kidney disease could also be 
used to stimulate awareness about a restrict glycemic control 
among diabetes patients. A better glycemic control could slow 
down the progression of CKD based on the outcome indicator 
of less than 50% of the patients that are able to reduce the 
progression of CKD, specifically those entering stage 4 or 5 
requiring CAPD or hemodialysis in tertiary care settings. 
However, a small number of stage 4 - 5 CKD were found in 
our study since they were referred back to community hospital 
for continuous care in addition to the dialysis at the tertiary 
care settings.17 The stage 5 CKD patients were taken care by 
palliative care concept by community hospital. 
Based on our findings and the context of community 
hospital, recommendations are as follows. More studies in 
diabetes patients with medications orther than anti-diabetic 
drugs and patients with other co-morbidities should be done 
to determine the outcomes. In addition, qualitative studies on 
health behaviors especially on self-care in diabetes patients 
to slow down kidney failure progression should be conducted. 
Such studies could also provide more understanding about 
patients with conflicting factors such as low HbA1C but 
positive alcohol intake.  
 In conclusion, more type 2 diabetes patients with stage1 
CKD was found, with a fewer number of patients in later 
stages. The decline of GFR in type 2 diabetes patients was 
associated with the increase in serum creatinine, HbA1C, 
serum BUN, alcohol or alcoholic beverage intake, BMI and 
duration of diabetes since diagnosed. 
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